Zephyrnet Logo

Tag: pediatric

Using AI and Robots To Build Social Connections For All Students

When Rebecca Ramnauth talks about AI and robots, she doesn’t speak about whether they will replace human tasks or facilitate more efficient teaching and...

Top News

Amsterdam-based Vini Mini secures €500k seed to prevent babies from getting food allergies | EU-Startups

Vini Mini, a preventive child healthcare startup, has announced a seed funding round of €500k. The Dutch startup has been backed in their previous...

Vapotherm’s HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America’s Largest Health Care Market | BioSpace

EXETER, N.H., Feb. 29, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), a global medical technology company specializing in the development...

Tech4SickKids – Innovate for a Healthier Tomorrow

Philanthropy | Feb 28, 2024Drive Change: Support Tech4SickKids NowWe're helping rally innovators, influencers, and drivers of change—to join Tech4SickKids in a monumental challenge: raising...

FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury | BioSpace

SCD-PED (Pediatric) is the first FDA-approved product in the Company’s Quelimmune™ product family DENVER, Feb. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq:...

The Big Pharma Double Standard – ADHD Medication and Meth: More Alike Than We’d Like to Admit

The Double Standards of Pharma: As adults, it's our responsibility to protect our youth and set them up for success. After all, they're the ones...

Better Living Through Biomedical Engineering

We don’t often think of medicine and engineering as being related concepts, and most of the time, they aren’t. But there’s a point where...

NeuroSigma Announces FDA Clearance of its Second-Generation Monarch eTNS System for Treating Pediatric ADHD | BioSpace

LOS ANGELES, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NeuroSigma today announced that the U.S. Food and Drug Administration (FDA) cleared use of NeuroSigma’s second-generation...

SeaStar Medical Appoints David A. Green as Chief Financial Officer | BioSpace

DENVER, Jan. 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

Occlutech(R) Announces FDA Approval of its Occlutech(R) ASD Occluder and Occlutech(R) Pistol Pusher, a Minimally Invasive Cardiac Device and Delivery System to Treat Atrial...

SCHAFFHAUSEN, CH / ACCESSWIRE / January 8, 2024 / Occlutech Holding AG Occlutech ASD Occluder delivers positive procedural outcomes with strong efficacy and a...

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury | BioSpace

DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences...

Global Nutraceuticals Market Outlook Report 2023-2028 Featuring Prominent Vendors BASF, Herbalife, Flavors & Fragrances, Nestle & Meiji Holdings – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Nutraceuticals Market – Global Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global nutraceuticals market is expected to grow...

Orthopedic Plate System at Center of Patent Infringement Suit

Plaintiff OrthoPediatrics Corp. (“OP”) filed a Complaint against fellow Warsaw, Indiana corporation, WishBone Medical, Inc. (“WishBone”).  They are alleging patent infringement concerning U.S. Patent...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?